BioMarin Pharmaceutical Inc. is a pioneer in the development and commercialization of innovative therapies targeting rare genetic disorders and serious medical conditions, firmly positioned in the biotechnology sector. Headquartered in San Rafael, California, the company leverages advanced science and technology to create targeted treatments that address significant unmet medical needs. With a strong portfolio of approved therapies and a dedicated focus on research and development, BioMarin is poised for sustained growth and is committed to enhancing the lives of patients affected by rare diseases.